CV Sciences (CVSI) Operating Margin (2013 - 2026)
CV Sciences' (CVSI) quarterly Operating Margin came in at 9.95% in Q1 2026, down 1026.0% year-on-year from 1.07% in Q1 2025, and down 267.93% quarter-over-quarter from 5.93% in Q4 2025.
CV Sciences (CVSI) Operating Margin (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Operating Margin across 14 years of filings, most recently posting 9.95% for Q1 2026.
- Operating Margin for Q1 2026 came in at 9.95%, down 1026.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.95% (up 624.0% YoY), and the FY2025 annual result was 1.44%, up 1250.0% from the prior year.
- Operating Margin came in at 9.95% for Q1 2026 at CV Sciences, down from 5.93% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 138.91% in Q1 2023 to a low of 55.94% in Q2 2022.
- The 5-year median for Operating Margin is 14.74% (2024), against an average of 9.56%.
- Across the five-year window, Operating Margin soared 17298 bps in 2023 and slumped 15440 bps in 2024, its largest moves.
- CV Sciences' Operating Margin stood at 54.92% in 2022, then jumped by 57 bps to 23.39% in 2023, then gained by 29 bps to 16.63% in 2024, then jumped by 136 bps to 5.93% in 2025, then slumped by 268 bps to 9.95% in 2026.
- The last three Operating Margin figures came in at 9.95% (Q1 2026), 5.93% (Q4 2025), and 8.45% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | CV Sciences | - | - | 1.56 Mn | -9.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.95% |
| Dec 31, 2025 | 5.93% |
| Sep 30, 2025 | -8.45% |
| Jun 30, 2025 | -3.62% |
| Mar 31, 2025 | 0.31% |
| Dec 31, 2024 | -16.63% |
| Sep 30, 2024 | -8.82% |
| Jun 30, 2024 | -14.74% |
| Mar 31, 2024 | -15.49% |
| Dec 31, 2023 | -23.39% |
| Sep 30, 2023 | -10.69% |
| Jun 30, 2023 | -27.13% |
| Mar 31, 2023 | 138.91% |
| Dec 31, 2022 | -54.92% |
| Sep 30, 2022 | -23.78% |
| Jun 30, 2022 | -55.94% |
| Mar 31, 2022 | -34.07% |
| Dec 31, 2021 | -177.96% |
| Sep 30, 2021 | -58.35% |
| Jun 30, 2021 | -68.45% |